Association of the immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination with computed tomography muscle images in patients with muscular disorders
The low immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination against MDs may be mainly affected by disease type and MD pathogenesis. However, SARS-CoV-2 immunization in patients with MDs warrants further investigation.
Authors
- Takahiro Watanabe‐Nakayama (ORCID: https://orcid.org/0000-0001-9758-3975)
- Tomoaki Naka
- Michinori Funato (ORCID: https://orcid.org/0000-0001-8836-8333)
- Satoshi Kuru
- Kunihiko Yasuda
Institutions
- Nagara Medical Center (JP)
- Suzuka University (JP)
- Yokohama Rosai Hospital (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3389/fimmu.2024.1479321
- Primary Topic
- Intramuscular injections and effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science